论文信息 - 1348POverall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: Results from two phase II studies - 字舞流文

1348POverall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: Results from two phase II studies

S. Vowler | P. Jänne | T. Mitsudomi | M. Ahn | L. Bazhenova | F. Blackhall | T. Hida | G. Laus | M. M. Tarruella | J.C. Yang